NCT02165735

Brief Summary

The purpose of this study is to rigorously assess a program designed to empower patient living with HIV, to improve their health care and health, and to reduce disparities.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
360

participants targeted

Target at P50-P75 for not_applicable hiv

Timeline
Completed

Started Aug 2014

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 13, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 17, 2014

Completed
2 months until next milestone

Study Start

First participant enrolled

August 20, 2014

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2016

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2017

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

October 9, 2018

Completed
Last Updated

March 15, 2019

Status Verified

February 1, 2019

Enrollment Period

2.3 years

First QC Date

June 13, 2014

Results QC Date

March 30, 2017

Last Update Submit

February 28, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Patient Activation Measure (PAM)

    Our primary outcome measure is patient empowerment based on changes in the Patient Activation Measure or PAM. The Patient Activation Measure (PAM) is a 13-item measure that assesses patient knowledge, skill, and confidence for self-management. People who score high on the PAM normally understand the importance of taking an active role in managing their health and have the skills and confidence to do so.The scores for the 13-item measure range in value from 0-100, with higher scores indicating greater activation. LEVEL 1 (0-47): May not yet believe that the patient role is important LEVEL 2 (47.1 - 55.1): Lacks confidence and knowledge to take action LEVEL 3 (55.2 - 67.0): Beginning to take action LEVEL 4 (67.1 - 100): Adapting new behaviors, but may have difficulty maintaining over time

    Baseline and 1 year

Secondary Outcomes (10)

  • Change in eHealth Literacy Scale (eHEALS)

    Baseline and 1 year

  • Change in Decisional Self-Efficacy Scale (DSES)

    Baseline and 1 year

  • Change in Perceived Involvement in Care Scale (PICS)

    Baseline and 1 year

  • Change in Instrument on Doctor Patient Communication Skills (IDPCS)

    Baseline and 1 year

  • Change in HIV Adherence Self-Efficacy Scale (ASES)

    Baseline and 1 year

  • +5 more secondary outcomes

Study Arms (2)

patient activation training

EXPERIMENTAL

Patient activation training involves six, 90-minute, group (8-12 person) training sessions facilitated by trained peers and training staff and one (20-30 minute) pre-visit coaching session conducted by staff. The hands on group training includes: 1) HIV education; 2) use of a handheld smart device; 3) use of an HIV electronic personal health record app that runs on the smart device; 4) identification of patients' visit need priorities and skills for communicating with their HIV provider. The pre-visit coaching includes identification patient concerns and patient behavioral rehearsal for asking about these concerns.

Behavioral: patient activation training

Usual Care

EXPERIMENTAL

Usual care for HIV

Other: Usual care

Interventions

Patient activation training involves six, 90-minute, group (8-12 person) training sessions facilitated by trained peers and training staff and one (20-30 minute) pre-visit coaching session conducted by staff. The hands on group training includes: 1) HIV education; 2) use of a handheld smart device; 3) use of an HIV electronic personal health record app that runs on the smart device; 4) identification of patients' visit need priorities and skills for communicating with their HIV provider. The pre-visit coaching includes identification of patient concerns and patient behavioral rehearsal for asking about these concerns.

patient activation training

Usual HIV care

Usual Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age18 years or older,
  • confirmed HIV diagnosis
  • receipt of care within a participating site.

You may not qualify if:

  • inability to provide informed consent
  • limited English proficiency (Trainings and Personal Health Record are currently only available in English)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Clinical Directors Network

New York, New York, 10018, United States

Location

University of Rochester

Rochester, New York, 14642, United States

Location

Related Publications (2)

  • Carroll JK, Tobin JN, Luque A, Farah S, Sanders M, Cassells A, Fine SM, Cross W, Boyd M, Holder T, Thomas M, Overa CC, Fiscella K. "Get Ready and Empowered About Treatment" (GREAT) Study: a Pragmatic Randomized Controlled Trial of Activation in Persons Living with HIV. J Gen Intern Med. 2019 Sep;34(9):1782-1789. doi: 10.1007/s11606-019-05102-7. Epub 2019 Jun 25.

  • Fiscella K, Boyd M, Brown J, Carroll J, Cassells A, Corales R, Cross W, El'Daher N, Farah S, Fine S, Fowler R, Hann A, Luque A, Rodriquez J, Sanders M, Tobin J. Activation of persons living with HIV for treatment, the great study. BMC Public Health. 2015 Oct 16;15:1056. doi: 10.1186/s12889-015-2382-1.

Results Point of Contact

Title
Dr. Kevin Fiscella, PI
Organization
University of Rochester

Study Officials

  • Kevin A Fiscella, MD MPH

    University of Rochester

    PRINCIPAL INVESTIGATOR
  • Jonathan Tobin, PhD

    Clinical Directors Network CDN

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, MPH

Study Record Dates

First Submitted

June 13, 2014

First Posted

June 17, 2014

Study Start

August 20, 2014

Primary Completion

November 30, 2016

Study Completion

February 28, 2017

Last Updated

March 15, 2019

Results First Posted

October 9, 2018

Record last verified: 2019-02

Locations